Optimizing first-line TKI treatment efficacy in PD-L1-positive EGFR-mutated NSCLC: the impact of antiangiogenic agents
Article in Frontiers in Pharmacology (August 2024)
The most recent citing publications are shown below. View all 2 publications that cite this research output on Dimensions.
Article in Frontiers in Pharmacology (August 2024)
Preprint in Research Square (January 2024)